Mvm Ag

BioVex's $70M Series F to Fund Pivotal OncoVex Melanoma Trial.
BIOWORLD Today; 11/11/2009; 1431 words; ...entirely by new investors. Morningside Venture, Ventech and MVM Life Science Partners co-led the second close, while Sectoral...Corp.'s elesclomol, Onyx Pharmaceuticals Inc. and Bayer AG's Nexavar (sorafenib), CancerVax Corp.'s Canvaxin and...

Other News To Note.
BIOWORLD Today; 11/4/2009; 2736 words; ...Alnylam enhanced its business with a merger with Ribopharma AG, of Kulmbach, Germany. o AlphaVax Inc., of Research Triangle...participating was ISIS Equity Partners plc, Merlin Biosciences Ltd., MVM Ltd., ABN-AMRO Participates BV, 3i and Green Highlander...

Unigene Hands Tarsa Phase III Asset as $24M Series A Closes.
BIOWORLD Today; 10/21/2009; 1449 words; ...rights for its calcitonin manufacturing technology to Novartis AG. Levy said that Unigene will continue to focus its efforts on...unique. The complex deal involved three venture capital groups - MVM Life Science Partners, Quaker BioVentures and Novo A/S - that...

Heptares Therapeutics Ltd., a two-year-old British biotech company, has raised 21 million pounds ($30.6 million) in private equity finance from Swiss drug giant Novartis AG and two venture capital firms.(Financing)(Brief article)
MondayMorning; 3/2/2009; 709 words; ...21 million pounds ($30.6 million) in private equity finance from Swiss drug giant Novartis AG and two venture capital firms. Clarus Ventures, MVM Life Science Partners and the Novartis Option Fund--a fund created by the Swiss drugmaker to...

Financings Roundup Serentis Will Use $20M Series A to Boost Dermatology Pipeline.
BIOWORLD Today; 8/13/2008; 1190 words; ...treatments for eczema: Elidel cream (pimecrolimus, Novartis AG) and Protopic ointment (tacrolimus, Astellas Pharma US Inc...3 million Series A financing co-led by founding investors MVM Life Science Partners LLP, Apposite Capital LLP and Novo A...